Cell Dissociation Market Report 2024

This Cell Dissociation market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The cell dissociation market size has grown rapidly in recent years. It will grow from $0.34 billion in 2023 to $0.38 billion in 2024 at a compound annual growth rate (CAGR) of 12.7%. The growth observed in the historic period can be linked to a rise in diabetes cases, a higher prevalence of infectious diseases, an increase in animal-based components, advancements in regenerative medicine, and a growing incidence of cancer.

The cell dissociation market size is expected to see rapid growth in the next few years. It will grow to $0.61 billion in 2028 at a compound annual growth rate (CAGR) of 12.8%. Looking ahead, growth is expected due to a surge in cell-based research approvals, more clinical trials, an increase in biopharmaceutical and pharmaceutical companies, a higher occurrence of chronic diseases, and a rise in neurological disorders. Key trends to watch during the forecast period include the development of personalized cell therapies, technological innovations, the launch of fingerprint-based drug testing, the introduction of enzymatic cell dissociation techniques, and the advancement of monoclonal antibodies.

The growing prevalence of chronic diseases is expected to drive the expansion of the cell dissociation market in the future. This increase in chronic conditions is linked to factors such as aging populations, lifestyle changes, and rising rates of obesity, physical inactivity, and poor diets, which contribute to long-term diseases such as diabetes, heart disease, and cancer. Cell dissociation plays a critical role in studying these diseases by allowing researchers to isolate and analyze individual cells, which helps in understanding disease mechanisms and developing targeted treatments. For example, an August 2022 report by the American College of Cardiology projected that all four major cardiovascular risk factors in the United States will rise significantly from 2025 to 2060. Diabetes is expected to see the most significant increase, rising by 39.3% to 55 million individuals, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). In addition, substantial increases in cardiovascular disease rates are anticipated, with stroke rising by 33.8% to 15 million, heart failure by 33.4% to 13 million, ischemic heart disease by 30.7% to 29 million, and heart attack by 16.9% to 16 million. Consequently, the rise in chronic diseases is propelling the growth of the cell dissociation market.

Leading companies in the cell dissociation market are concentrating on creating advanced products such as cell depletion and enrichment kits to gain a competitive edge. These kits are designed to selectively remove or enrich specific cell populations, enhancing the efficiency and accuracy of research and clinical applications. For instance, in February 2023, LevitasBio, a US-based biotechnology firm, introduced the LeviSelect Suite of Cell Depletion & Enrichment Kits. These kits feature high-speed processing and minimal impact on cell viability, making them ideal for sensitive research environments. Additionally, the LeviSelect kits offer customizable protocols, enabling researchers to precisely target a wide variety of cell types.

In March 2023, Agilent Technologies, a US-based company, acquired e-MSion for an undisclosed amount. This acquisition is designed to enhance Agilent's capabilities in biopharmaceutical development by integrating advanced analytical solutions into its existing portfolio. e-MSion is a US-based early-stage company specializing in innovative electron capture dissociation (ECD) technology.

Major companies operating in the cell dissociation market are Roche Holding AG, Danaher Corporation, Fujifilm Holdings Corporation, Becton Dickinson and Company, GE HealthCare Technologies Inc., Corning Incorporated, Lonza Group AG, Bio-Rad Laboratories Inc., Eppendorf AG, Bio-Techne Corporation, Miltenyi Biotec, BioLegend Inc., Cyagen Biosciences Inc., Cell Signaling Technology Inc., HiMedia Laboratories LLC, Gemini Bio-Products, Biological Industries USA Inc., BrainBits LLC, Biocompare Inc., AAT Bioquest Inc.

North America was the largest region in the cell dissociation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell dissociation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell dissociation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Cell dissociation involves isolating cells from tissues or cell cultures to create a single-cell suspension. This is accomplished through enzymatic, mechanical, or chemical techniques, ensuring that the cells remain viable and functional for subsequent use. It is a vital procedure for various research, diagnostic, and therapeutic tasks. Proper cell dissociation is essential for accurate analyses and applications in fields such as flow cytometry, cell culture, and single-cell sequencing.

Cell dissociation products mainly include enzymatic dissociation, non-enzymatic dissociation, instruments, and accessories. Enzymatic dissociation utilizes specific enzymes to degrade the extracellular matrix, allowing cells to be separated from tissues for further examination. This method applies to both epithelial and connective tissues and is used for tissue dissociation and cell detachment. Key users of these products include pharmaceutical and biotechnology companies, research and academic institutions, clinical research organizations (CROs), and others.

The cell dissociation market research report is one of a series of new reports that provides cell dissociation market statistics, including cell dissociation industry global market size, regional shares, competitors with a cell dissociation market share, detailed cell dissociation market segments, market trends and opportunities, and any further data you may need to thrive in the cell dissociation industry. This cell dissociation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell dissociation market consists of revenues earned by entities by providing services such as mechanical dissociation, adherent cell dissociation using enzymes, and suspension cell dissociation via gentle centrifugation. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell dissociation market also includes sales of cell dissociation buffers, gentle dissociation reagents, and chelating agents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.